TrialDiabetes, obesity & metabolism2019

Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia.

Ronnie Aronson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.